logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Angina Unstable

    FiltersReset Filters
    11 results

    • enoxaparin sodium

      (Enoxaparin Sodium)
      Meitheal Pharmaceuticals Inc.
      Usage: Enoxaparin Sodium Injection is indicated for the prophylaxis and treatment of deep vein thrombosis (DVT), including for patients undergoing specific surgeries or with restricted mobility. It also prevents ischemic complications in unstable angina and treats acute ST-segment elevation myocardial infarction (STEMI) when used with aspirin.

    • enoxaparin sodium

      (Enoxaparin Sodium)
      Meitheal Pharmaceuticals Inc.
      Usage: Enoxaparin Sodium Injection is indicated for the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism, prevention of ischemic complications in unstable angina and non-Q-wave myocardial infarction, and treatment of acute ST-segment elevation myocardial infarction (STEMI) when used with aspirin.

    • enoxaparin sodium

      (Enoxaparin sodium)
      Amphastar Pharmaceuticals, Inc.
      Usage: Enoxaparin Sodium Injection is indicated for the prophylaxis and treatment of deep vein thrombosis (DVT), including acute cases. It also prevents ischemic complications in unstable angina and non-Q-wave myocardial infarction, and treats acute ST-segment elevation myocardial infarction (STEMI) when used with aspirin.

    • enoxaparin sodium

      (Enoxaparin Sodium)
      Fresenius Kabi USA, LLC
      Usage: Enoxaparin sodium injection is indicated for the prophylaxis and treatment of deep vein thrombosis (DVT) and pulmonary embolism (PE), as well as for the prevention of ischemic complications in unstable angina and non-Q-wave myocardial infarction. Additionally, it aids in treating acute ST-segment elevation myocardial infarction.

    • enoxaparin sodium

      (Enoxaparin sodium)
      BluePoint Laboratories
      Usage: Enoxaparin Sodium Injection is indicated for the prophylaxis of deep vein thrombosis (DVT) in surgical and medical patients, treatment of acute DVT with warfarin, prophylaxis of ischemic complications in unstable angina and myocardial infarction, and treatment of acute ST-segment elevation myocardial infarction (STEMI) with aspirin.

    • enoxaparin sodium

      (enoxaparin sodium)
      Fresenius Kabi USA, LLC
      Usage: Enoxaparin sodium is indicated for the prophylaxis of deep vein thrombosis (DVT) in at-risk patients, treatment of acute DVT with or without pulmonary embolism, prophylaxis of ischemic complications in unstable angina, and treatment of acute ST-segment elevation myocardial infarction (STEMI) alongside aspirin.

    • fragmin

      (Dalteparin Sodium)
      Pfizer Laboratories Div Pfizer Inc
      Usage: FRAGMIN is indicated for the prophylaxis of ischemic complications in unstable angina and non-Q-wave myocardial infarction, deep vein thrombosis (DVT) prevention in surgical and at-risk patients, extended treatment of symptomatic VTE in cancer patients, and VTE treatment in pediatric patients. It is not for acute VTE treatment.

    • lovastatin

      (lovastatin)
      Lupin Pharmaceuticals, Inc.
      Usage: Lovastatin is indicated for lowering total and LDL cholesterol levels as part of a treatment strategy in individuals with dyslipidemia at risk for atherosclerotic vascular disease, including those with coronary heart disease and hypercholesterolemia. It is also used for primary prevention of coronary heart disease in certain populations.

    • prasugrel

      (Prasugrel)
      Accord Healthcare Inc.
      Usage: Prasugrel is indicated for reducing thrombotic cardiovascular events in acute coronary syndrome patients undergoing percutaneous coronary intervention. This includes those with unstable angina, non-ST-elevation myocardial infarction, and ST-elevation myocardial infarction, showing efficacy in decreasing cardiovascular death and nonfatal myocardial infarction compared to clopidogrel.

    • verapamil hydrochloride

      (VERAPAMIL HYDROCHLORIDE)
      Chartwell RX, LLC
      Usage: Verapamil hydrochloride is indicated for treating angina (including vasospastic and unstable types), controlling ventricular rates in arrhythmias, prophylaxis of paroxysmal supraventricular tachycardia, and managing essential hypertension to reduce cardiovascular event risks such as strokes and myocardial infarctions.